Ophthalmology Biosimilars Market Size, Share & Industry Analysis, By Drug Class (Anti-VEGF Antibodies, VEGF Fusion Proteins, and TNF-alpha Inhibitors), By Product (Ranibizumab Biosimilars, Aflibercept Biosimilars, and Adalimumab Biosimilars), By Application (Wet Age-related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, and Retinal Vein Occlusion), By Age Group (Pediatric and Adults), By Route of Administration (Intravitreal and Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Specialty Pharmacies), and Regional Forecast, 2026-2034